Clinical
Explore Aiforia’s comprehensive portfolio of high-performance AI solutions, engineered for both clinical and preclinical applications. Aiforia’s solutions aim to enhance the speed, accuracy, and consistency of analyzing large and complex medical images, especially in pathology.
Learn moreResearch
Aiforia’s research solutions offer fully automated study-centric workflows and pathology image analysis applications that cater to all research areas. Empowered by robust AI capabilities, pathologists and scientists can make discoveries while saving time by automating repetitive tasks – also within the framework of GLP. Aiforia’s solutions can be integrated with any existing laboratory infrastructure to enjoy the full benefits of a digitized workflow.
Learn moreAiforia® Create is the most versatile tool for developing deep learning AI models for image analysis in digital pathology. Its cloud-based, collaborative working environment allows multiple users to work together in real time, anywhere in the world. Praised for its intuitive user interface, it allows users a fast start, even without any prior AI experience.Learn more >
Learn moreExplore Aiforia’s comprehensive portfolio of high-performance AI solutions, engineered for both clinical and preclinical applications. Aiforia’s solutions aim to enhance the speed, accuracy, and consistency of analyzing large and complex medical images, especially in pathology.
Learn moreAI development tool
Aiforia® Create is the most versatile tool for developing deep learning AI models for image analysis in digital pathology. Its cloud-based, collaborative working environment allows multiple users to work together in real time, anywhere in the world. Praised for its intuitive user interface, it allows users a fast start, even without any prior AI experience.
Learn moreResources
Explore some of our latest publications showcasing the discoveries enabled by the Aiforia® Platform.
Learn moreAiforia's insights and resources for AI in pathology. View some of our content pieces from the world of AI.
Learn moreStay updated with Aiforia’s recent announcements. Explore our latest news, updates and announcements.
Learn moreCompany
Find out more about shareholder matters, investment discussions, and financial-related information.
Learn moreAiforia's mission is to transform pathology image analysis with AI, enabling better care for each patient. To succeed, we need our trusted partners. Explore Aiforia’s partner network.
Learn moreExperience our AI solutions firsthand. Explore the list of conferences where you can connect with Aiforia’s team live and book a time to discover the future of AI-powered image analysis.
Learn moreOur mission is to transform pathology image analysis with AI, enabling better care for each patient. Find out more about job openings, thesis opportunities, or submitting applications.
Learn moreAiforia Technologies holds information security to the highest standard. We hold several, globally relevant quality and security certifications, so you can be sure your sensitive information is safe.
Learn moreClinical
Clinical Solutions
AI solutions portfolio
Research
AI development tool
Aiforia® Create
Resources
Company
About us
Investors
Partners
Media
Events
Careers
Quality and security
Yeasts are common microorganisms used in industrial fermentation processes such as food and alcohol production. Microbial contamination of such processes is inevitable, as most of the fermentation substrates are not sterile. Contamination can cause a reduction of the final product concentration and render industrial yeast strains unable to be reused. Hence, contamination detection is critical to maximizing production efficiency and the quality of products. Often, this process involves plating assays, although results may take days to obtain, after which manual analysis of the plates is also tedious. Lallemand Inc., a yeast production company, is speeding up the process using Aiforia® Create’s automated AI image analysis models.
Lallemand’s R&D lab in Tallinn, Estonia, the Competence Centre for Food and Fermentation Technologies, focuses on yeast derivative production process optimization and yeast-derived bioactive compound research. We spoke with Ildar Nisamedtinov, VP of Research & Development Coordination, to learn more about applying Aiforia’s AI models to support research and development on yeast fermentation contamination.
Ildar Nisamedtinov: "We aimed to use AI-powered image analysis technology for identification of contamination in yeast fermentations. As a manufacturer of yeast starter cultures we want to make sure that our products are clean of microbial contamination.
In most cases, the conventional methods for contamination detection rely on plating assays, which for some microorganisms may take several days until results are obtained. We do not want to replace these assays but use them in parallel with a rapid and robust analysis method, which would allow us to make decisions in production more proactively. An AI-based microscopy image analysis might be an efficient and quick quality test method for this purpose."

"Aiforia is already actively selling its image analysis technology in the medical field (e.g., tumor cell detection), so we were sure it would also fit our requirements. Their proximity to our R&D lab in Tallinn, Estonia, was also a positive."
"We expect to develop a robust and rapid detection method of microbial contamination in our products, which would allow us to minimize quality associated business risks. It is not ready yet, but we are working hard in collaboration with Aiforia to get there."
"Like many other companies, we at Lallemand are also embarking on the Industry 4.0 journey. The given project with Aiforia is one piece of our general goal to move towards full digitization of the entire yeast production process, including quality control. As a result, we expect to improve the production process efficiency and quality of our products."
Read more case studies:
References
Seung-Oh et al. (2020). Anti-Contamination Strategies for Yeast Fermentations. Microorganisms, 8(2), 274; https://doi.org/10.3390/microorganisms8020274